Hypoparathyroidism: is it time for replacement therapy?
作者信息
Horwitz Mara J, Stewart Andrew F
出版信息
J Clin Endocrinol Metab. 2008 Sep;93(9):3307-9. doi: 10.1210/jc.2008-1216.
Abstract
摘要
相似文献
1
Hypoparathyroidism: is it time for replacement therapy?甲状旁腺功能减退症：是时候进行替代治疗了吗？
J Clin Endocrinol Metab. 2008 Sep;93(9):3307-9. doi: 10.1210/jc.2008-1216.
2
A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides.甲状旁腺激素肽：甲状旁腺功能减退症慢性管理的新时代。
Front Horm Res. 2019;51:165-171. doi: 10.1159/000491047. Epub 2018 Nov 19.
3
Parathyroid hormone therapy for hypoparathyroidism.甲状旁腺功能减退症的甲状旁腺激素治疗
Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):47-55. doi: 10.1016/j.beem.2014.09.001. Epub 2014 Sep 10.
4
Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?甲状旁腺激素替代治疗能否改善慢性甲状旁腺功能减退症患者的生活质量？
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2752-2755. doi: 10.1210/jc.2017-02593.
5
Hypoparathyroidism.甲状旁腺功能减退症
Endocrinol Metab Clin North Am. 2018 Dec;47(4):xiii. doi: 10.1016/j.ecl.2018.09.002.
6
Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.甲状旁腺功能减退症的甲状旁腺激素替代疗法：一项荟萃分析。
Horm Metab Res. 2016 Jun;48(6):377-83. doi: 10.1055/s-0042-106970. Epub 2016 Jun 2.
7
The REPLACE study in adults and calcilytics.成人及钙化溶解剂方面的REPLACE研究。
Ann Endocrinol (Paris). 2015 May;76(2):180-2. doi: 10.1016/j.ando.2015.03.023. Epub 2015 Apr 25.
8
Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.重组人生长激素 (1-84)：甲状旁腺功能减退症的综述。
Drugs. 2015 Jul;75(11):1293-303. doi: 10.1007/s40265-015-0438-2.
9
Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.甲状旁腺功能减退症和原发性甲状旁腺功能亢进症患者恢复正常甲状旁腺状态后的骨骼变化。
Endocrine. 2017 Feb;55(2):591-598. doi: 10.1007/s12020-016-1101-8. Epub 2016 Oct 18.
10
Quality of Life in Hypoparathyroidism.甲状旁腺功能减退症患者的生活质量。
Endocrinol Metab Clin North Am. 2018 Dec;47(4):855-864. doi: 10.1016/j.ecl.2018.07.010. Epub 2018 Oct 11.
引用本文的文献
1
A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review.高浓度透析液镁以降低肌肉痉挛频率：一项叙述性综述。
Can J Kidney Health Dis. 2020 Oct 22;7:2054358120964078. doi: 10.1177/2054358120964078. eCollection 2020.
2
Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).甲状旁腺功能减退症患者接受和未接受 rhPTH(1-84)治疗的 5 年估计肾小球滤过率。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):e3557-65. doi: 10.1210/clinem/dgaa490.
3
Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.儿童甲状旁腺功能减退症的长期甲状旁腺激素 1-34 替代治疗。
J Pediatr. 2018 Dec;203:391-399.e1. doi: 10.1016/j.jpeds.2018.08.010.
4
Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.特立帕肽治疗甲状旁腺功能减退症患者的疗效：一项前瞻性、开放标签研究。
Indian J Endocrinol Metab. 2017 May-Jun;21(3):415-418. doi: 10.4103/ijem.IJEM_340_16.
5
Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.重组人生长激素 (1-84)：甲状旁腺功能减退症的综述。
Drugs. 2015 Jul;75(11):1293-303. doi: 10.1007/s40265-015-0438-2.
6
22q11 deletion syndrome: current perspective.22q11缺失综合征：当前观点
Appl Clin Genet. 2015 May 18;8:123-32. doi: 10.2147/TACG.S82105. eCollection 2015.
7
Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.在患有严重先天性甲状旁腺功能减退症的儿童中，泵注射与每日两次注射合成甲状旁腺激素1-34的效果比较。
J Pediatr. 2014 Sep;165(3):556-63.e1. doi: 10.1016/j.jpeds.2014.04.060. Epub 2014 Jun 16.
8
Questionable safety of thyroid surgery with same day discharge.甲状腺手术当日出院的安全性存疑。
Ann R Coll Surg Engl. 2012 Nov;94(8):543-7. doi: 10.1308/003588412X13373405384576.
9
Hypocalcemia: updates in diagnosis and management for primary care.低钙血症：初级保健中诊断和管理的最新进展。
Can Fam Physician. 2012 Feb;58(2):158-62.
10
Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.合成人甲状旁腺激素 1-34 替代治疗：一项比较泵与注射治疗慢性甲状旁腺功能减退症的随机交叉试验。
J Clin Endocrinol Metab. 2012 Feb;97(2):391-9. doi: 10.1210/jc.2011-1908. Epub 2011 Nov 16.
本文引用的文献
1
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.甲状旁腺激素1-34每日一次与每日两次治疗对甲状旁腺功能减退症儿童的影响。
J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95. doi: 10.1210/jc.2007-2552. Epub 2008 May 20.
2
On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).关于人甲状旁腺激素（1-34）和人甲状旁腺激素（1-84）大鼠致癌性研究的解读
J Bone Miner Res. 2008 Jun;23(6):803-11. doi: 10.1359/jbmr.080208.
3
Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.特立帕肽[人甲状旁腺激素（1-34）]：关于该药物治疗骨质疏松症的使用及安全性的2.5年经验。
J Bone Miner Res. 2006 Mar;21(3):354-65. doi: 10.1359/JBMR.051023. Epub 2005 Nov 11.
4
Translational implications of the parathyroid calcium receptor.甲状旁腺钙受体的转化意义
N Engl J Med. 2004 Jul 22;351(4):324-6. doi: 10.1056/NEJMp048153.
5
Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.甲状旁腺功能减退症的长期治疗：一项比较甲状旁腺激素（1-34）与骨化三醇及钙剂的随机对照研究。
J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20. doi: 10.1210/jc.2002-021736.
6
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.甲状旁腺激素（1-34）对绝经后骨质疏松症女性骨折及骨密度的影响。
N Engl J Med. 2001 May 10;344(19):1434-41. doi: 10.1056/NEJM200105103441904.
7
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.一项针对伴有或不伴有甲状旁腺手术的原发性甲状旁腺功能亢进症的10年前瞻性研究。
N Engl J Med. 1999 Oct 21;341(17):1249-55. doi: 10.1056/NEJM199910213411701.
8
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.一项关于每日一次与每日两次甲状旁腺激素1-34治疗甲状旁腺功能减退症的随机交叉试验。
J Clin Endocrinol Metab. 1998 Oct;83(10):3480-6. doi: 10.1210/jcem.83.10.5185.
9
10
Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.人甲状旁腺激素-（1-34）氨基末端片段的皮下给药：雌激素化骨质疏松症患者的动力学和生化反应
J Clin Endocrinol Metab. 1993 Dec;77(6):1535-9. doi: 10.1210/jcem.77.6.8263137.
Zotero 插件